M&A Deal Summary |
|
|---|---|
| Date | 2017-12-20 |
| Target | Alizé Pharma SAS |
| Sector | Life Science |
| Buyer(s) | Millendo Therapeutics |
| Deal Type | Add-on Acquisition |
SEARCH BY
Millendo Therapeutics is focused on developing novel treatments for endocrine diseases. Millendo Therapeutics creates distinct and transformative treatments for a wide range of diseases where there is a significant unmet medical need. Millendo Therapeutics is based in Ann Arbor, Michigan.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 2 |
| Sector: Life Science M&A | 1 of 2 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| Country: France M&A | 1 of 1 |
| Year: 2017 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-11-01 |
OvaScience
Waltham, Massachusetts, United States OvaScience, Inc. is a life sciences company dedicated to improving fertility for women. OvaScience was founded in 2011 and is based in Waltham, Massachusetts. |
Buy | - |
